Diagnosis and Prevention of Atherosclerotic Cerebral Infarction
暂无分享,去创建一个
[1] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[2] J. Matías‐Guiu. [Epidemiology of cerebrovascular disease]. , 2000, Revista espanola de cardiologia.
[4] R. Sacco,et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. , 1995, Stroke.
[5] G J Boerma,et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). , 1995, Circulation.
[6] E S Fisher,et al. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. , 1998, JAMA.
[7] H. Diener,et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.
[8] C. Zarins,et al. Carotid Bifurcation Atherosclerosis: Quantitative Correlation of Plaque Localization with Flow Velocity Profiles and Wall Shear Stress , 1983, Circulation research.
[9] E. Hutchinson,et al. Controlled Trial of Dipyridamole in Cerebral Vascular Disease , 1969, British medical journal.
[10] H. Adams,et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.
[11] C. Doherty,et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. , 1997, Stroke.
[12] Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. , 2003 .
[13] L. Wilkins. European Stroke Prevention Study. ESPS Group. , 1990, Stroke.
[14] K. Furie,et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.
[15] A. Khandji,et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis , 2003, Neurology.
[16] L. Chambless,et al. High‐Resolution B‐Mode Ultrasound Reading Methods in the Atherosclerosis Risk in Communities (ARIC) Cohort , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[17] J M Johnson,et al. Natural history of asymptomatic carotid plaque. , 1985, Archives of surgery.
[18] L. Wilkins. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group. , 1985 .
[19] E. Falk. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. , 1983, British heart journal.
[20] J. Kirkpatrick,et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. , 1998, Journal of insurance medicine.
[21] R. Peto,et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial , 2004, The Lancet.
[22] J. Toole,et al. Cigarette smoking cessation and extracranial carotid atherosclerosis. , 1989, JAMA.
[23] M. Metcalfe,et al. Dipyridamole , 1992, The Lancet.
[24] A. Einstein,et al. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group. , 1985, Stroke.
[25] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[26] A. Folsom,et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. , 1996, The New England journal of medicine.
[27] M. Brown,et al. A Randomised Controlled Trial of Vitamin E in Patients with Coronary Disease: The Cambridge Heart Antioxidant Study (CHAOS) , 1996 .
[28] R. Collins,et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.
[29] D. Sackett,et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. , 1998, The New England journal of medicine.
[30] J. Salonen,et al. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. , 1993, Circulation.
[31] C. Fisher,et al. Atherosclerosis of the Carotid and Vertebral Arteries—Extracranial and Intracranial , 1965 .
[32] S. Kjeldsen,et al. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study]. , 2003, Ugeskrift for laeger.
[33] P. Yarnold,et al. Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases , 1998, Annals of Internal Medicine.
[34] R. Lusby,et al. Carotid plaque hemorrhage. Its role in production of cerebral ischemia. , 1982, Archives of surgery.
[35] Z Vokó,et al. J-shaped relation between blood pressure and stroke in treated hypertensives. , 1999, Hypertension.
[36] À. Rovira,et al. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis , 2004, Neurology.
[37] Z. Ruggeri,et al. Mechanisms of Shear-induced Platelet Adhesion and Aggregation , 1993, Thrombosis and Haemostasis.
[38] P. R. R. Ecurrent,et al. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .
[39] J. Woo,et al. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. , 1990, Archives of neurology.
[40] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[41] V. Fuster,et al. Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real time B-mode ultrasonography. , 1988, Journal of the American College of Cardiology.
[42] R. Lusby,et al. Carotid artery atheroma: ultrasound appearance in symptomatic and asymptomatic vessels. , 1989, The Australian and New Zealand journal of surgery.
[43] T. Riles,et al. The Importance of Hemorrhage in the Relationship Between Gross Morphologic Characteristics and Cerebral Symptoms in 376 Carotid Artery Plaques , 1983, Annals of surgery.
[44] J. Weinberger,et al. The Prevalence of Asymptomatic Intracranial Large‐Vessel Occlusive Disease: The Role of Diabetes , 2003, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[45] C. Furberg,et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) , 1995, The American journal of cardiology.
[46] R. Weinshilboum,et al. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.
[47] M. B. Brown,et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study , 1995, Neurology.
[48] C. Furberg,et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.
[49] L. Reilly,et al. Carotid plaque histology using real-time ultrasonography. Clinical and therapeutic implications. , 1983, American journal of surgery.
[50] I. Kronzon,et al. Atheromatosis of the aortic arch as an occult source of multiple systemic emboli. , 1991, Annals of internal medicine.
[51] Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. , 1995, JAMA.
[52] J. Weinberger,et al. Mechanisms in Lacunar Infarction , 1992, Stroke.
[53] J. Weinberger,et al. Natural history of aortic arch atherosclerotic plaque , 2000, Neurology.
[54] Azar,et al. A COMPARISON OF WARFARIN AND ASPIRIN FOR THE PREVENTION OF RECURRENT ISCHEMIC STROKE , 2001 .
[55] F. Setacci,et al. Protected Carotid Stenting: Clinical Advantages and Complications of Embolic Protection Devices in 442 Consecutive Patients , 2003, Stroke.
[56] George Howard,et al. High‐resolution B‐Mode Ultrasound Scanning Methods in the Atherosclerosis Risk in Communities Study (ARIC) , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[57] Karla Kerlikowske,et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials , 1999, The Lancet.
[58] R. Robinson,et al. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. , 2003, The American journal of psychiatry.
[59] Deepak L. Bhatt,et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. , 2002, The American journal of cardiology.
[60] V. Fuster,et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. , 1994, Journal of the American College of Cardiology.
[61] P. L. Walton,et al. Pharmacological Evaluation of Ticlopidine, A Novel Inhibitor of Platelet Function , 1977, Thrombosis and Haemostasis.
[62] J. Weinberger,et al. Plaque morphology correlates with cerebrovascular symptoms in patients with complex aortic arch plaque. , 2000, Archives of neurology.
[63] D. Levy,et al. Endovascular stents for carotid artery occlusive disease. , 1997 .
[64] J. Kresh,et al. Intrinsic cardiac neuroendocrine system mediates ischemic myocardial adaptation , 1998 .
[65] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.
[66] J. Oates,et al. Drug therapy. Dipyrimadole , 1987 .
[67] M. Woodward,et al. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .
[68] J. Halperin,et al. Noninvasive evaluation of the extracranial carotid arteries in patients with cerebrovascular events and atrial fibrillations. , 1988, Archives of internal medicine.
[69] C. Fisher,et al. Lacunes , 1965, Neurology.
[70] T. Bajwa,et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. , 2004, The New England journal of medicine.
[71] M-heart investigators. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS) , 1994, The Lancet.
[72] N. Bornstein,et al. Vascular Risks of Asymptomatic Carotid Stenosis , 1991, Stroke.
[73] F. Yatsu. Vascular Disease of the Central Nervous System 0 443 02415 4 R.W. , 1984, Trends in Neurosciences.
[74] A. Labovitz,et al. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. , 1998, Journal of the American College of Cardiology.
[75] H. Blumenthal,et al. An Autopsy Study of Cerebrovascular Accident in Diabetes Mellitus , 1962, Circulation.
[76] J. Ausman,et al. Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. , 2000, Archives of neurology.
[77] I. Kronzon,et al. Disappearance of a large intraaortic mass in a patient with prior systemic embolization. , 1993, American heart journal.
[78] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .
[79] M. Ezekowitz,et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. , 2001, JAMA.
[80] D. Reid,et al. Stenting in the carotid artery: initial experience in 110 patients. , 1996 .
[81] J. Rothrock,et al. Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. , 1994, Archives of internal medicine.
[82] A. Hofman,et al. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). , 2004, Journal of the American College of Cardiology.
[83] T. Chalmers,et al. Drug treatment of hypertension in the elderly: a meta-analysis. , 1994, Annals of internal medicine.
[84] J. Cutler,et al. Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.
[85] T. Chalmers,et al. Drug Treatment of Hypertension in the Elderly , 1994, Annals of Internal Medicine.
[86] David Gladstone. Review article , 2005, Health Care Analysis.
[87] M. Pfeffer,et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. , 1999, Circulation.
[88] T. Merimee,et al. Diabetic retinopathy. A synthesis of perspectives. , 1990, The New England journal of medicine.
[89] R. Lusby,et al. The role of plaque morphology and diameter reduction in the development of new symptoms in asymptomatic carotid arteries. , 1989, Journal of vascular surgery.
[90] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[91] R. Holman,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. , 1998 .
[92] P. Majerus,et al. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. , 1975, The Journal of clinical investigation.
[93] H. Diener,et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.
[94] B. Davis,et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). , 2000, JAMA.
[95] I. Kronzon,et al. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. , 2002, The American journal of cardiology.
[96] Edward B. Diethrich,et al. Stenting in the Carotid Artery: Initial Experience in 110 Patients , 1996, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.
[97] Michael F. Oliver,et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study. , 2001, Indian heart journal.
[98] D. Levy,et al. Endovascular Stents for Carotid Artery Occlusive Disease , 1997, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.
[99] M. Nieminen,et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. , 2002, JAMA.
[100] F A Jolesz,et al. Detection of internal carotid artery stenosis: comparison of MR angiography, color Doppler sonography, and arteriography. , 1992, Radiology.
[101] G. Hankey. Ongoing and Planned Trials of Antiplatelet Therapy in the Acute and Long-Term Management of Patients with Ischaemic Brain Syndromes: Setting a New Standard of Care , 2004, Cerebrovascular Diseases.
[102] J. Blackshear,et al. Variable effect of anticoagulation in the treatment of severe protruding atherosclerotic aortic debris. , 1994, American heart journal.
[103] Richard J. Snow,et al. Indications, outcomes, and provider volumes for carotid endarterectomy. , 1998, JAMA.
[104] A. Luft,et al. Identification of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting. , 2000, Stroke.
[105] E. Falk,et al. Homocysteine and atherothrombosis , 2001, Lipids.
[106] M. Pfeffer,et al. Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein , 1999 .
[107] J. Badimón,et al. Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model. , 1989, The Journal of clinical investigation.
[108] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[109] F. Gorstein,et al. The Carotid Bifurcation Plaque: Pathologic Findings Associated with Cerebral Ischemia , 1979, Stroke.
[110] J. Bogousslavsky,et al. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. , 1988, Stroke.
[111] Adel M. Malek,et al. Stent Angioplasty for Cervical Carotid Artery Stenosis in High-Risk Symptomatic NASCET-Ineligible Patients , 2000, Stroke.
[112] J. Grotta,et al. Prevention of stroke with ticlopidine , 1992, Neurology.
[113] M. Nieminen,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .
[114] D. Sackett,et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. , 1991, The New England journal of medicine.
[115] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[116] J. Weinberger,et al. Atherosclerotic plaque at the carotid artery bifurcation. Correlation of ultrasonographic imaging with morphology. , 1987, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[117] A. D. Hall,et al. Importance of emboli from carotid bifurcation in pathogenesis of cerebral ischemic attacks. , 1970, Archives of surgery.
[118] M. Dennis. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .
[119] S M Nazarian,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.
[120] V. Fuster,et al. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.